Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Meilahti Tower Hospital

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Meilahti Tower Hospital is part of Helsinki University Hospital. The hospital treats patients in the specialties of cardiac and thoracic surgery, vascular surgery, gastrointestinal surgery, and neurology. All adult organ transplants in Finland are nationally centralized at the hospital. In neurology, the Tower Hospital also provides nationwide telemedicine services for thrombolytic treatment of stroke.The Tower Hospital has outpatient clinics for several medical specialties, as well as services that support diagnosis and treatment, including laboratory and imaging services, a physiotherapy unit, and a neurological rehabilitation assessment unit.The hospital works closely with the neighboring Meilahti Triangle Hospital, and the two hospitals share a main entrance.

Business Status

Source: Google. OPEN

Business Category

Source: Google. University hospital

Business Subcategory

Source: Google. University hospital
Source: Google. Hospital
Source: Trial-derived.
31Total Trials
Source: Trial-derived.
6Recruiting Trials
Source: Trial-derived.
14Active Trials
Source: Trial-derived.
14Completed Trials
Source: Trial-derived.
64Unique Conditions
Source: Trial-derived.
36Unique Sponsors

Conditions

Source: Trial-derived. Appendicitis (3)Source: Trial-derived. Acute Non-cardioembolic Ischemic Stroke (2)Source: Trial-derived. Coronary Artery Disease (2)Source: Trial-derived. Hypercholesterolemia (2)Source: Trial-derived. Ischemic Heart Disease (2)Source: Trial-derived. Parkinson Disease (2)Source: Trial-derived. Prostate Cancer (2)Source: Trial-derived. Abdominal Pain (1)

Sponsors

Source: Trial-derived. Helsinki University Central Hospital (12)Source: Trial-derived. Bayer (5)Source: Trial-derived. Hospital District of Helsinki and Uusimaa (4)Source: Trial-derived. University of Helsinki (3)Source: Trial-derived. Astellas Pharma Inc (2)Source: Trial-derived. Medivation LLC, a wholly owned subsidiary of Pfizer Inc. (2)Source: Trial-derived. Merck Sharp & Dohme LLC (2)Source: Trial-derived. Pfizer (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment